Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.

Bilici, AhmetGumus, MahmutOdabas, HaticeKandemir, NurtenDemirci, UmutCihan, SenerBayoglu, Ibrahim Vedat2024-04-242024-04-2420160732-183X1527-7755https://doi.org/10.1200/JCO.2016.34.15_suppl.e16051https://hdl.handle.net/11468/18297Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 03-07, 2016 -- Chicago, IL[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.Conference Object3415WOS:00040471150002910.1200/JCO.2016.34.15_suppl.e16051Q1